You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Birch triterpenes - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for birch triterpenes and what is the scope of patent protection?

Birch triterpenes is the generic ingredient in one branded drug marketed by Chiesi and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Birch triterpenes has eighty-six patent family members in thirty-three countries.

Two suppliers are listed for this compound.

Summary for birch triterpenes
International Patents:86
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 2
Clinical Trials: 2
What excipients (inactive ingredients) are in birch triterpenes?birch triterpenes excipients list
DailyMed Link:birch triterpenes at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for birch triterpenes
Generic Entry Date for birch triterpenes*:
Constraining patent/regulatory exclusivity:
TREATMENT OF WOUNDS ASSOCIATED WITH DYSTROPHIC AND JUNCTIONAL EPIDERMOLYSIS BULLOSA (EB) IN ADULT AND PEDIATRIC PATIENTS 6 MONTHS OF AGE AND OLDER
Dosage:
GEL;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for birch triterpenes

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Minia UniversityPhase 1
Oregon Health and Science UniversityPhase 2
National Center for Complementary and Integrative Health (NCCIH)Phase 2

See all birch triterpenes clinical trials

US Patents and Regulatory Information for birch triterpenes

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi FILSUVEZ birch triterpenes GEL;TOPICAL 215064-001 Dec 18, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chiesi FILSUVEZ birch triterpenes GEL;TOPICAL 215064-001 Dec 18, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chiesi FILSUVEZ birch triterpenes GEL;TOPICAL 215064-001 Dec 18, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chiesi FILSUVEZ birch triterpenes GEL;TOPICAL 215064-001 Dec 18, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for birch triterpenes

Country Patent Number Title Estimated Expiration
Portugal 2504012 ⤷  Sign Up
Mexico 2020006995 EXTRACTOS DE CORTEZA DE ABEDUL QUE CONTIENEN BETULINA Y SU FORMULACION. (BETULIN-CONTAINING BIRCH BARK EXTRACTS AND THEIR FORMULATION.) ⤷  Sign Up
Russian Federation 2020125679 БЕТУЛИН-СОДЕРЖАЩИЕ ЭКСТРАКТЫ ИЗ БЕРЕЗОВОЙ КОРЫ И СОСТАВ НА ИХ ОСНОВЕ ⤷  Sign Up
Austria E423546 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for birch triterpenes

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1758555 353 5017-2016 Slovakia ⤷  Sign Up PRODUCT NAME: BETULIN; REGISTRATION NO/DATE: EU/1/15/1069/001 20160118
1758555 641 Finland ⤷  Sign Up
1758555 1690031-8 Sweden ⤷  Sign Up PRODUCT NAME: BETULIN; REG. NO/DATE: EU/1/15/1069 20160118
1758555 16C1003 France ⤷  Sign Up PRODUCT NAME: BETULINE; REGISTRATION NO/DATE: EU/1/15/1069 20160118
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.